Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01605396 |
|---|---|
| Brief Title: | A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064) |
| First Submitted : | May 22, 2012 |
| First Submitted that Met QC Criteria : | May 22, 2012 |
| First Posted : | May 24, 2012 (Estimate) |
| Results First Submitted : | February 15, 2019 |
| Results First Submitted that Met QC Criteria : | March 21, 2019 |
| Results First Posted : | March 25, 2019 |
| Last Update Submitted that Met QC Criteria : | March 21, 2019 |
| Last Update Posted : | March 25, 2019 |